FutureFemHealth

FutureFemHealth

Home
Work with us / Advertise
CensHERship
Archive
About
Clue and Ovum partner to bring affordable fertility tools to UK consumers
Ovum now exclusive distributor of Clue Plus in the UK within the fertility supplements and pregnancy testing category
 • 
FutureFemHealth
Winona launches menopause community app as stigma-busting support network goes digital
Connection, resources and real-world events for women navigating midlife hormonal changes.
 • 
FutureFemHealth
Progyny partners with ŌURA to bring wearable health insights into reproductive care — from preconception to menopause
Progyny has become the latest women’s health company to partner with ŌURA, maker of the popular smart ring, bringing wearable data directly into its…
 • 
FutureFemHealth
Daré Bioscience secures $6m funding installment as smart contraceptive device eyes expansion into obesity and diabetes
DARE-LARC1 is a long-acting reversible contraceptive currently in preclinical development.
 • 
FutureFemHealth
💌 Issue 109: The earpiece reducing period pain | Plexāā secures $4.5m to support US launch | WeightWatchers pivots to menopause | Organon…
+ lots more in your weekly round-up of women's health innovation and FemTech news
 • 
FutureFemHealth
WeightWatchers eyes menopause care as it emerges from financial overhaul and returns to Nasdaq
Company appoints Dr Kim Boyd as Chief Medical Officer and announces tailored programme for midlife women
 • 
FutureFemHealth
UK MedTech startup Plexāā secures $4.5m to support US launch of breast surgery device
Extends previous seed round
 • 
FutureFemHealth
OhmBody launches wearable earpiece to reduce pain and heaviness of periods
Hormone-free, neurostimulation for period relief
 • 
FutureFemHealth
💌 Issue 108: Women's health leaders call on big tech | Escala's $4.5m for POP device | UK roll-out for Carevix | 'Plastic-free' periods row
+ lots more in your weekly round-up of women's health and FemTech news
 • 
FutureFemHealth
2
Juniper Genomics lands $4.6m seed funding to launch world-first whole-genome embryo test
New standard of care for IVF genetic testing
 • 
FutureFemHealth
Escala completes $4.5 million funding round for pelvic organ prolapse device 'Mendit'
Backed by EU innovation fund
 • 
FutureFemHealth

June 2025

© 2025 FutureFemHealth
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture